Malaway (Proguanil Hydrochloride, Atovaquone)

The combination works through two complementary mechanisms. Atovaquone blocks the mitochondrial electron transport chain of the malaria parasite, halting ATP production. Proguanil is converted in the body to cycloguanil, which inhibits the parasite’s dihydrofolate reductase enzyme, preventing folate synthesis. Together they produce a synergistic effect that stops parasite replication.

The dosing regimen for Malaway is individualized and must be determined by a qualified prescriber based on the indication, patient weight, age, renal and hepatic function, and local resistance patterns. Patients should follow the exact instructions provided on the prescription label and consult their healthcare professional for any clarification.

Safety data for Malaway in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus. Breastfeeding mothers should discuss the drug with their physician, as small amounts may be excreted in breast milk and could affect the infant.

To place an order, visit the product page for Malaway on the GNH India website (gnhindia.com) and submit an enquiry with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Malaway offers a convenient fixed‑dose combination that provides both prophylactic and therapeutic coverage against Plasmodium falciparum. Compared with alternatives such as doxycycline or mefloquine, it has a shorter daily dosing schedule and a different side‑effect profile, often preferred for patients who cannot tolerate the neuropsychiatric effects of mefloquine or the photosensitivity of doxycycline.

Malaway tablets should be stored at ambient temperature, below 25 °C, in their original blister pack or container. Keep the product away from moisture, direct sunlight and excessive heat to maintain stability and potency throughout its shelf life.

Malaway is taken orally with a full glass of water, preferably with food or a milky drink to improve absorption of atovaquone. The tablets should be swallowed whole and not crushed or chewed unless specifically directed by a healthcare professional.

Serious adverse events, although rare, include severe skin reactions such as Stevens‑Johnson syndrome, significant liver injury, hemolytic anemia, severe neutropenia, and anaphylactic hypersensitivity. Patients should seek immediate medical attention if they develop rash, jaundice, unexplained fatigue, fever, or signs of an allergic reaction.

Malaway is contraindicated in individuals with known hypersensitivity to atovaquone, proguanil, or any component of the formulation. It should be avoided in patients with severe renal impairment unless dose adjustment is made, and in those with a history of severe hepatic disease or serious skin reactions to related antimalarial agents.